These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27035518)

  • 1. Impact of multicellular tumor spheroids as an in vivo‑like tumor model on anticancer drug response.
    Galateanu B; Hudita A; Negrei C; Ion RM; Costache M; Stan M; Nikitovic D; Hayes AW; Spandidos DA; Tsatsakis AM; Ginghina O
    Int J Oncol; 2016 Jun; 48(6):2295-302. PubMed ID: 27035518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.
    Yoshii Y; Furukawa T; Aoyama H; Adachi N; Zhang MR; Wakizaka H; Fujibayashi Y; Saga T
    Int J Oncol; 2016 Apr; 48(4):1477-84. PubMed ID: 26820693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the spheroid model complexity on drug response.
    Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
    J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
    Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Kouchak M; Amini M; Angali KA; Saremy S; Dorkoosh FA
    Biomed Pharmacother; 2018 Dec; 108():1259-1273. PubMed ID: 30372827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
    Zeghari-Squalli N; Raymond E; Cvitkovic E; Goldwasser F
    Clin Cancer Res; 1999 May; 5(5):1189-96. PubMed ID: 10353756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity of the seaweed compound fucosterol, alone and in combination with 5-fluorouracil, in colon cells using 2D and 3D culturing.
    Ramos AA; Almeida T; Lima B; Rocha E
    J Toxicol Environ Health A; 2019; 82(9):537-549. PubMed ID: 31258008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells.
    Raymond E; Louvet C; Tournigand C; Coudray AM; Faivre S; De Gramont A; Gespach C
    Int J Oncol; 2002 Aug; 21(2):361-7. PubMed ID: 12118332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
    LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB
    Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New folate receptor targeted nano liposomes for delivery of 5-fluorouracil to cancer cells: Strong implication for enhanced potency and safety.
    Handali S; Moghimipour E; Kouchak M; Ramezani Z; Amini M; Angali KA; Saremy S; Dorkoosh FA; Rezaei M
    Life Sci; 2019 Jun; 227():39-50. PubMed ID: 31002921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Resazurin Reduction Assay Can Distinguish Cytotoxic from Cytostatic Compounds in Spheroid Screening Assays.
    Walzl A; Unger C; Kramer N; Unterleuthner D; Scherzer M; Hengstschläger M; Schwanzer-Pfeiffer D; Dolznig H
    J Biomol Screen; 2014 Aug; 19(7):1047-59. PubMed ID: 24758920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalized layer-by-layer assembled film with directional 5-fluorouracil release to target colon cancer.
    Janardhanam LSL; Indukuri VV; Verma P; Dusane AC; Venuganti VVK
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111118. PubMed ID: 32600718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles.
    Tidwell TR; Røsland G; Tronstad KJ; Søreide K; Hagland HR
    Cancer Med; 2024 Jun; 13(11):e7318. PubMed ID: 38872378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
    Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
    Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.
    Vasilevskaya IA; Selvakumaran M; Hierro LC; Goldstein SR; Winkler JD; O'Dwyer PJ
    Clin Cancer Res; 2015 Sep; 21(18):4143-52. PubMed ID: 26023085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and Combination Drug Screening with Aqueous Biphasic Tumor Spheroids.
    Shahi Thakuri P; Tavana H
    SLAS Discov; 2017 Jun; 22(5):507-515. PubMed ID: 28324660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.